Newsletter | February 23, 2024

02.23.24 -- Services, Technologies, And Innovations In Fill/Finish

Aseptic Manufacturing Services

At Singota Solutions, robotic aseptic filling is done in a completely gloveless workcell that provides highly repeatable, precision fills for small batch manufacturing, ideally suited for the production of pre-clinical, clinical, and niche commercial injectable products.

Request Information

Singota Solutions

High-Speed Filling Line For Vials

IDT Biologika has expanded its capacities of eight dedicated aseptic filling lines by a new high-speed line. With batch sizes of up to 500,000 vials, this is one of the fastest in the world and can serve up to 100 million vials per year.

Request Information

IDT Biologika

Expanding The Boundaries Of Sub-Cutaneous Injections

The goal at Lonza is to help our customers who are breaking new ground in biologics by supporting them in the development and manufacturing of their target drug product profile.

Request Information

Lonza

Future-Proof Your Aseptic Filling

Using the Cytiva SA25 Aseptic Filling Workcell, a standardized system designed with flexibility built in, ensures that you can quickly pivot between products and adapt as manufacturing needs change.

Request Information

Resilience US, Inc.

Scalable Manufacturing Of Sterile Drug Products

Discover comprehensive clinical to commercial scale manufacturing services that deliver true life-cycle management for sterile drug products that bring treatments to patients with efficiency and quality.

Request Information

PCI Pharma Services

EZ-Fill A Fully Integrated Ready-To-Use Solution For Your Aseptic Manufacturing

Stevanato Group boasts a range of commercially available products geared towards specific biopharmaceutical requirements. The SG EZ-fill® platform includes vials, cartridges, and syringes that are sterilized and ready-to-fill.

Request Information

Stevanato Group

Key Financial Considerations For Phase 2 Clinical Injectable Drug Manufacturing

Review the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.

Request Information

INCOG BioPharma Services

Primary Drug Containers

Oval’s proprietary primary drug containers offer a wide range of benefits over traditional glass based systems. The use of cyclic olefin copolymer (COC) allows for much greater design flexibility, and the creation of more robust containers.

Request Information

SMC Ltd.

A CDMO With Oral Solid Dose And Sterile Injectable Expertise

Societal™ CDMO offers capabilities spanning pre-IND development to commercial manufacturing and packaging. Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.

Request Information

Societal CDMO

Combination Products

Kymanox provides turnkey services to bring your product from concept to commercialization — and helps keep your product on the market. Kymanox has expertise in injectables, respiratory combination products, and in ocular products.

Request Information

Kymanox Corporation